default author photo

Ernest Fraenkel

Harvard University - Department of Data Science

SCHOLARLY PAPERS

2

DOWNLOADS

125

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Selective CDK7 Inhibition Has Dual Activity in Treatment Resistant Estrogen Receptor Positive Breast Cancer

Number of pages: 63 Posted: 20 Apr 2023
Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Biomedical Informatics, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Center for Functional Cancer Epigenetics, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Baylor University - Lester and Sue Smith Breast Center, Azienda USL Toscana Centro - Bioinformatics Unit, Harvard University - Department of Oncologic Pathology, Harvard T.H. Chan School of Public Health - Department of Biostatistics, Baylor University - Department of Molecular and Cellular Biology, Harvard University - Lurie Family Imaging Center, Harvard University - Department of Oncologic Pathology, Azienda USL Toscana Centro - Sandro Pitigliani Translational Research Unit, Harvard University - Department of Cancer Biology, Harvard University - Department of Cancer Biology, Harvard University - Department of Data Science, Baylor University - Lester and Sue Smith Breast Center, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute and Independent
Downloads 79 (809,932)

Abstract:

Loading...

CDK7, breast cancer, ER positive, endocrine resistance, ESR1 mutant, CDK4/6 inhibitor resistance, Cell Cycle, CRISPR screen

2.

Integration of Transcriptomics, Proteomics and Loss-of-Function Screening Reveals Wee1 as a Target for Combination with Dasatinib Against Proneural Glioblastoma

Number of pages: 40 Posted: 13 Aug 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Heidelberg University - University Hospital Heidelberg, affiliation not provided to SSRN, Heidelberg University - Central Institute of Mental Health, affiliation not provided to SSRN, Heidelberg University - Central Institute of Mental Health, University of Queensland, QIMR Berghofer Medical Research Institute, Heidelberg University - University Hospital Heidelberg, Heidelberg University - University Hospital Heidelberg, Technische Universität München (TUM) - Department of Neurosurgery, Harvard University - Department of Data Science, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 46 (1,109,210)

Abstract:

Loading...

Phosphoproteomics, computational integration, Loss-of-function shRNA screen, dasatinib, WEE1